Time-restricted feeding and risk of metabolic disease: a review of human and animal studies - PubMed Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2014 May;72(5):308-18.
doi: 10.1111/nure.12104. Epub 2014 Apr 16.

Time-restricted feeding and risk of metabolic disease: a review of human and animal studies

Jeff Rothschild  1 , Kristin K Hoddy, Pera Jambazian, Krista A Varady
Affiliations
Review

Time-restricted feeding and risk of metabolic disease: a review of human and animal studies

Jeff Rothschild et al. Nutr Rev. 2014 May.

Abstract

Time-restricted feeding (TRF), a key component of intermittent fasting regimens, has gained considerable attention in recent years. TRF allows ad libitum energy intake within controlled time frames, generally a 3-12 hour range each day. The impact of various TRF regimens on indicators of metabolic disease risk has yet to be investigated. Accordingly, the objective of this review was to summarize the current literature on the effects of TRF on body weight and markers of metabolic disease risk (i.e., lipid, glucoregulatory, and inflammatory factors) in animals and humans. Results from animal studies show TRF to be associated with reductions in body weight, total cholesterol, and concentrations of triglycerides, glucose, insulin, interleukin 6, and tumor necrosis factor-α as well as with improvements in insulin sensitivity. Human data support the findings of animal studies and demonstrate decreased body weight (though not consistently), lower concentrations of triglycerides, glucose, and low-density lipoprotein cholesterol, and increased concentrations of high-density lipoprotein cholesterol. These preliminary findings show promise for the use of TRF in modulating a variety of metabolic disease risk factors.

Keywords: coronary heart disease; intermittent fasting; metabolic syndrome; time-restricted feeding; weight loss.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

See all "Cited by" articles